PV Reporter interviews Dr. Jean-Jacques Kiladjian at ASH 2017, video 1 - YouTube
J.J. Kiladjian (@jjkiladjian) / Twitter
Armenian Hematology Association - Prof. Jean-Jacques Kiladjian Lecture topic “Myelofibrosis in 2015. New therapies and stem cell transplantation” Jean-Jacques Kiladjian is Professor of Clinical Pharmacology, consultant Haematologist, and head of the ...
OncLive - WATCH: Jean-Jacques Kiladjian, MD, PhD, of... | Facebook
CONTI-PV: a 2-year follow-up of interferon product AOP2014
Update on Management of ET/PV with ruxolitinib – MPN-MDSEU-2020.COM
Ropeg in polycythemia vera: long-term PROUD-PV and CONTI-PV results | VJHemOnc
Dr. Jean Jacques Kiladjian at ASH 2017 - PV Reporter
☎️ Contacts du Dr Jean Jacques Kiladjian, Hematologue à Paris 75010
Ropeginterferon Effective Treatment for Polycythemia Vera | PV Reporter
Jean-Jacques Kiladjian | Page 2 of 5 | VJHemOnc
Dr. Kiladjian on Ruxolitinib Plus Interferon in MPNs
The importance of patient registries | VJHemOnc
Pr Jean-Jacques Kiladjian : « Améliorer le diagnostic des cancers du sang doit être une priorité nationale. Des initiatives comme Septembre rouge vont nous y aider.» - Opinion Internationale
Jean-Jacques Kiladjian | VJHemOnc
ASH 2020: Practice-changing abstracts for MPN
J.J. Kiladjian (@jjkiladjian) / Twitter
Results for the follow-up of the RESPONSE study - YouTube
Dr. Jean Jacques Kiladjian ASH 2018 interview with David ...
Long-term 5-year data continues to show RESPONSE to ruxolitinib in polycythemia vera - YouTube
Jean-Jacques Kiladjian | VJHemOnc
Dr. Kiladjian on Ruxolitinib Plus Interferon in MPNs - YouTube
Auteur - Pr Jean-Jacques KILADJIAN
